RYTM

Rhythm Pharmaceuticals INC

-$1.4B

Net Activity

Institutions Holding

287

Popularity Rank

#2080

Avg Weight

0.34%

Total Value

$6.4B

Ownership Trend

287 institutions currently hold RYTM, with 157 net buyers and 144 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

144

Net Buying Institutions

157

Key Holders

View all 287 holding institutions

Quarterly Activity

Recent Activity

+$2.7B

Total Buy Value

$3.4B

Total Sell Value

New buy55
Trim93
Add102
Sold out51

157

Net Buyers

144

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

1

Filings (90d)

$3.58M

Total Est. Value

37K shares

Planned Shares

Last Filed 2026-06-22
FilerFiling DateEst. Value
TETRAULT LYNN A.2026-06-22$3.58M

Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding RHYTHM PHARMACEUTICALS INC (RYTM)?
Major stakeholders currently include Ra Capital Management, L.p. ($579.8M), BlackRock, Inc. ($542.4M), Baker Bros. Advisors LP ($487.4M). Based on the latest 13F filings, there are a total of 287 tracked investment funds and institutions maintaining positions in RYTM.
What is the overall institutional sentiment toward RYTM recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $1.4B, driven by 157 managers accumulating shares while 144 reduced their exposure.
Which institutions have been selling or reducing their RYTM positions?
In the latest period, 93 funds trimmed their holdings, and 51 managers completely exited their positions. The aggregate reported sell value was $3.4B.
Are there any notable investors adding RYTM to their portfolios?
Yes, buying activity remains notable. 55 institutions opened new positions in {ticker}, and 102 existing holders added to their shares. The total reported buy value for the quarter amounted to $2.7B.

Related Stocks